Thanks, Ohm. I guess it's a nice problem to have when your drug has such wide-ranging actions.
How about conjugating LL with a checkpoint inhibitor? As I understand it, those MOAs are different. Not beating a dead horse, just interested in the conjugation route, as far as I know that hasn't been discussed much.